Evidence map›Paper›PMID 35203712›Full record

ArticleBiomedicines2022

Cytoprotective Effect of Idebenone through Modulation of the Intrinsic Mitochondrial Pathway of Apoptosis in Human Retinal Pigment Epithelial Cells Exposed to Oxidative Stress Induced by Hydrogen Peroxide.

Maria Elisabetta Clementi, Michela Pizzoferrato, Giada Bianchetti, Anna Brancato, Beatrice Sampaolese, Giuseppe Maulucci, Giuseppe Tringali

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Different Therapeutic Approaches for Dry and Wet AMD.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. A Vicious NGF-p75International journal of molecular sciences · 2023
    Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Protective Effects ofAntioxidants (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Maria Elisabetta ClementiInstitute of Chemical Sciences and Technologies "Giulio Natta" (SCITEC)-CNR, Largo F. Vito 1, 00168 Rome, Italy.ORCID 0000-0002-4615-7826
Michela PizzoferratoPharmacology Section, Department of Health Care Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.
Giada BianchettiFondazione Policlinico Universitario Agostino Gemelli IRCSS, 00168 Rome, Italy.ORCID 0000-0003-1257-2295
Anna BrancatoDepartment of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties of Excellence "G. D'Alessandro", University of Palermo, 90127 Palermo, Italy.ORCID 0000-0002-8635-4146
Beatrice SampaoleseInstitute of Chemical Sciences and Technologies "Giulio Natta" (SCITEC)-CNR, Largo F. Vito 1, 00168 Rome, Italy.ORCID 0000-0001-7833-1801
Giuseppe MaulucciFondazione Policlinico Universitario Agostino Gemelli IRCSS, 00168 Rome, Italy.ORCID 0000-0002-2154-319X
Giuseppe TringaliPharmacology Section, Department of Health Care Surveillance and Bioethics, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Rome, Italy.ORCID 0000-0002-1030-9429
Università Cattolica del Sacro Cuore · ITIstituto di Scienze e Tecnologie Chimiche "Giulio Natta"University of Palermo · IT

Funding

Fondi di Ateneo D1: 2020-2021 D1: 2020-2021
6 · The paper itself

Abstract

Idebenone is a ubiquinone short-chain synthetic analog with antioxidant properties, which is believed to restore mitochondrial ATP synthesis. As such, idebenone is investigated in numerous clinical trials for diseases of mitochondrial aetiology and it is authorized as a drug for the treatment of Leber's hereditary optic neuropathy. Mitochondria of retinal pigment epithelium (RPE) are particularly vulnerable to oxidative damage associated with cellular senescence. Therefore, the aim of this study was to explore idebenone's cytoprotective effect and its underlying mechanism. We used a human-RPE cell line (ARPE-19) exposed to idebenone pre-treatment for 24 h followed by conditions inducing H

Indexed as

apoptosisARPE-19 (human-RPE cell line)idebenonemitochondrianuclear factor erythroid 2-related factor (Nrf2)oxidative stress

Identifiers

PMID35203712
PMCPMC8962354
OpenAlexW4213354388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.